Catalyst Funds Management Pty »

Galectin Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $63k 23k 2.79

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Galectin Therapeutics

Vanguard Group
Vanguard Capital Management
Advisor Group Holdings
Susquehanna International
Dr. Jeffrey R. Jay, M.D.
BlackRock
Millennium Management
Sontag Advisory
Geode Capital Management
Marshall Wace
Two Sigma Investments
Commonwealth Equity Services
Citadel Advisors
Jane Street
Vanguard Fiduciary Trust

View all funds holding Galectin Therapeutics